These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Randomized, controlled trial of clonidine for smoking cessation in a primary care setting. Franks P; Harp J; Bell B JAMA; 1989 Dec; 262(21):3011-3. PubMed ID: 2681856 [TBL] [Abstract][Full Text] [Related]
29. Varying nicotine patch dose and type of smoking cessation counseling. Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558 [TBL] [Abstract][Full Text] [Related]
30. Buspirone effect on tobacco withdrawal symptoms: a randomized placebo-controlled trial. Robinson MD; Pettice YL; Smith WA; Cederstrom EA; Sutherland DE; Davis H J Am Board Fam Pract; 1992; 5(1):1-9. PubMed ID: 1561909 [TBL] [Abstract][Full Text] [Related]
31. Does smoking abstinence influence distress tolerance? An experimental study comparing the response to a breath-holding test of smokers under tobacco withdrawal and under nicotine replacement therapy. Cosci F; Anna Aldi G; Nardi AE Psychiatry Res; 2015 Sep; 229(1-2):89-93. PubMed ID: 26233827 [TBL] [Abstract][Full Text] [Related]
32. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. Glassman AH; Stetner F; Walsh BT; Raizman PS; Fleiss JL; Cooper TB; Covey LS JAMA; 1988 May; 259(19):2863-6. PubMed ID: 3367452 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642 [TBL] [Abstract][Full Text] [Related]
35. Effects of nicotine versus placebo e-cigarette use on symptom relief during initial tobacco abstinence. Perkins KA; Karelitz JL; Michael VC Exp Clin Psychopharmacol; 2017 Aug; 25(4):249-254. PubMed ID: 28650184 [TBL] [Abstract][Full Text] [Related]
36. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers. Demazières A; Luthringer R; Coppel E; Gilles C; Fleury C; Roegel JC; Delarue A; Laur C; Lagrue G Addict Behav; 2006 Mar; 31(3):537-43. PubMed ID: 15964703 [TBL] [Abstract][Full Text] [Related]
37. Nicotine patches and the subjective effects of cigarette smoking: a pilot study. Cárdenas L; Busto UE; MacDonald A; Corrigall WA Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575 [TBL] [Abstract][Full Text] [Related]
38. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years. Kisicki JC; Fiske K; Lyne A Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196 [TBL] [Abstract][Full Text] [Related]
39. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791 [TBL] [Abstract][Full Text] [Related]
40. The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms. Charney DS; Sternberg DE; Kleber HD; Heninger GR; Redmond DE Arch Gen Psychiatry; 1981 Nov; 38(11):1273-7. PubMed ID: 7305608 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]